Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Vyvanse (Lisdexamfetamine Dimesylate) Capsules
Company: New River Pharmaceuticals Inc.
Application No.:  021977
Approval Date: 02/23/2007


Date created: March 312007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.